Phosphagenics CEO steps down
Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.
The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.
The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.
Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
